PubMed Health⌕ Search

PubMed · 10275532

Efficiently-run practices--ways to keep costs in line.

Abstract

Containment of health care costs is a serious concern today for everyone, including the local, state and federal governments, industry and the private sector. Physicians are looked at as the "bad guys" in the cost containment battle as publicity focuses on the high cost of office visits, procedures, tests and hospital charges. When you add to that the additional image of the "rich doctor," it is easy to understand why so much attention is paid to the doctor as the perceived reason for the high costs of care. Medical practices are also guilty of fostering that image as patients perceive an inefficient approach about the business side of medicine. And, as an inefficient office usually adds to a practice's overhead, someone must be expected to cover that extra cost. That someone, unfortunately, is the patient--either by a direct payment of increased fees or by the added cost of the insurance premium. What follows are some basic items of good business management that should help cut your practice expenses, whether you are solo or part of a group practice. The streamlining of your practice should enable you to keep your costs--and your fees--in line. And, as medicine changes with health maintenance organizations and preferred provider organizations becoming more of a factor, it will be essential for your practice to be cost efficient to compete.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D R Sweeney. 1986. Efficiently-run practices--ways to keep costs in line.. https://pubmed.ncbi.nlm.nih.gov/10275532/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Cancer care, money, and the value of life: whose justice? Which rationality?

Cost-containment in oncology is a moral issue. While economists use the word "rationing" to describe all limitations on resource utilization that result from human choice, the ordinary language distinction between allocation and rationing is morally meaningful and can help oncologists to determine their proper moral role in cost-containment. It is argued that oncologists should not be required to ration at the bedside, nor should they be given financial incentives to practice frugally, nor should they be subjected to a variety of bureaucratic mechanisms to control costs indirectly. In addition, it is argued that the fact that treatments have a price does not logically imply that patients have a price. Cost-effectiveness analysis is often suggested as a means of deciding how best to allocate resources, but some of its many ethical limitations are discussed. The alternative is an open, public, participatory process about how to ration care, abandoning the formulaic pretenses of cost-effectiveness analysis, but with a commitment to reason, good will, and common sense. Oncologists would then be free to advocate for their patients within the constraints imposed by this public process.

Cost Control↗

Documentation of pharmacists' interventions in an emergency department and associated cost avoidance.

PURPOSE: An analysis was conducted of pharmacist interventions and resuscitation experiences, including pharmacist participation in a hospital emergency department (ED), and the potential cost avoidance associated with the interventions made by the pharmacists. METHODS: All pharmacists working in the ED prospectively documented the pharmacist interventions that were accepted by physicians and nursing staff and entered into a spreadsheet on a weekly basis, between September 1, 2003, and December 31, 2003. Intervention categories included the provision of drug information; recommendations for dosage adjustment, formulary interchange, initiation of medications, alternative drug therapy, discontinuation of drug therapy, changes in medication therapy due to allergy notification, drug therapy duplication prevention, or changes in the route of drug administration; questions from nursing staff; order clarifications; drug compatibility issues; patient information; toxicology; and drug interaction identification. Intervention data were analyzed and the likelihood of harm was scored; interventions were classified and analyzed by calculating average cost, probability of harm, and potential cost avoidance. RESULTS: During the study, 2150 pharmacist interventions were documented. Pharmacists participated in the care of 1042 patients triaged to the resuscitation area of the ED. Cost avoidance during the study was determined to be 1,029,776 dollars. CONCLUSION: The most commonly documented interventions made by pharmacists involved in the care of patients visiting the ED included provision of drug information, dosage adjustment recommendations, responses to questions from nursing staff, formulary interchanges, and suggestions regarding initiation of drug therapy. The potential cost avoidance attributable to the pharmacist interventions during the study period was over 1 million dollars.

Cost Control↗